Literature DB >> 21145972

NGF activation of TrkA induces vascular endothelial growth factor expression via induction of hypoxia-inducible factor-1α.

Katsuya Nakamura1, Fei Tan, Zhijie Li, Carol J Thiele.   

Abstract

Communication between the vasculature and nervous system is important during embryogenesis but the molecular mechanisms mediating this are ill-defined. We evaluated the molecular mechanisms by which Nerve Growth Factor (NGF) and Brain-derived neurotrophic factor (BDNF) regulate VEGF production. NGF activation of TrkA causes a marked increase in VEGF secretion by neuronal cells. The NGF induced increase in VEGF is accompanied by an increase in HIF-1α. Pharmacologic inhibitors of the Trk tyrosine kinase, PI-3 kinase and mTOR paths prevent NGF stimulated increases in HIF-1α and VEGF. NGF induced increase in VEGF transcription is dependent on a hypoxia response element (HRE) in the VEGF promoter. Mutation of the HRE or siRNA mediated silencing of HIF-1α expression blocks NGF induced increases in VEGF transcription. In primary cultures of TrkA expressing neurons from dorsal root ganglion, NGF induces VEGF expression that is accompanied by increases in HIF-1α but not HIF-2α expression. In CGN neurons, BDNF induces VEGF that is dependent on induction of HIF-1α. Our study indicates that neurotrophin activation of Trk stimulates an increase in VEGF transcription that is mediated by induction of HIF-1α. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21145972      PMCID: PMC3044333          DOI: 10.1016/j.mcn.2010.12.002

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  37 in total

1.  Sensory nerves determine the pattern of arterial differentiation and blood vessel branching in the skin.

Authors:  Yoh-suke Mukouyama; Donghun Shin; Stefan Britsch; Masahiko Taniguchi; David J Anderson
Journal:  Cell       Date:  2002-06-14       Impact factor: 41.582

2.  Expression of the neurotrophin receptor TrkA down-regulates expression and function of angiogenic stimulators in SH-SY5Y neuroblastoma cells.

Authors:  Angelika Eggert; Michael A Grotzer; Naohiko Ikegaki; Xing-ge Liu; Audrey E Evans; Garrett M Brodeur
Journal:  Cancer Res       Date:  2002-03-15       Impact factor: 12.701

3.  Nerve growth factor control of neuronal expression of angiogenetic and vasoactive factors.

Authors:  L Calza; L Giardino; A Giuliani; L Aloe; R Levi-Montalcini
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-20       Impact factor: 11.205

4.  Up-regulation of insulin-like growth factor-II expression is a feature of TrkA but not TrkB activation in SH-SY5Y neuroblastoma cells.

Authors:  C J Kim; T Matsuo; K H Lee; C J Thiele
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

5.  Nerve growth factor induces angiogenic activity in a mouse model of hindlimb ischemia.

Authors:  Paolo Turrini; Carlo Gaetano; Alessia Antonelli; Maurizio C Capogrossi; Luigi Aloe
Journal:  Neurosci Lett       Date:  2002-04-26       Impact factor: 3.046

6.  Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment.

Authors:  Koichi Hattori; Beate Heissig; Yan Wu; Sergio Dias; Rafael Tejada; Barbara Ferris; Daniel J Hicklin; Zhenping Zhu; Peter Bohlen; Larry Witte; Jan Hendrikx; Neil R Hackett; Ronald G Crystal; Malcolm A S Moore; Zena Werb; David Lyden; Shahin Rafii
Journal:  Nat Med       Date:  2002-07-01       Impact factor: 53.440

7.  CCM2 mediates death signaling by the TrkA receptor tyrosine kinase.

Authors:  Liraz Harel; Barbara Costa; Marianna Tcherpakov; Marc Zapatka; Andre Oberthuer; Loen M Hansford; Milijana Vojvodic; Zehava Levy; Zhe-Yu Chen; Francis S Lee; Smadar Avigad; Isaac Yaniv; Leming Shi; Roland Eils; Matthias Fischer; Benedikt Brors; David R Kaplan; Mike Fainzilber
Journal:  Neuron       Date:  2009-09-10       Impact factor: 17.173

8.  Hypoxia-induced cell death and changes in hypoxia-inducible factor-1 activity in PC12 cells upon exposure to nerve growth factor.

Authors:  Nico Charlier; Norbert Leclere; Ursula Felderhoff; Julia Heldt; Thomas Kietzmann; Michael Obladen; Johann Gross
Journal:  Brain Res Mol Brain Res       Date:  2002-07-15

9.  Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.

Authors:  Annamaria Rapisarda; Badarch Uranchimeg; Dominic A Scudiero; Mike Selby; Edward A Sausville; Robert H Shoemaker; Giovanni Melillo
Journal:  Cancer Res       Date:  2002-08-01       Impact factor: 12.701

10.  Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization.

Authors:  M J Donovan; M I Lin; P Wiegn; T Ringstedt; R Kraemer; R Hahn; S Wang; C F Ibañez; S Rafii; B L Hempstead
Journal:  Development       Date:  2000-11       Impact factor: 6.868

View more
  24 in total

1.  Sustained delivery of VEGF maintains innervation and promotes reperfusion in ischemic skeletal muscles via NGF/GDNF signaling.

Authors:  Dmitry Shvartsman; Hannah Storrie-White; Kangwon Lee; Cathal Kearney; Yevgeny Brudno; Nhi Ho; Christine Cezar; Corey McCann; Erin Anderson; John Koullias; Juan Carlos Tapia; Herman Vandenburgh; Jeff W Lichtman; David J Mooney
Journal:  Mol Ther       Date:  2014-04-28       Impact factor: 11.454

2.  Angiotensin receptor type 2 activation induces neuroprotection and neurogenesis after traumatic brain injury.

Authors:  Gali Umschweif; Sigal Liraz-Zaltsman; Dalia Shabashov; Alexander Alexandrovich; Victoria Trembovler; Michal Horowitz; Esther Shohami
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

Review 3.  Targeting VEGF and Its Receptors for the Treatment of Osteoarthritis and Associated Pain.

Authors:  John L Hamilton; Masashi Nagao; Brett R Levine; Di Chen; Bjorn R Olsen; Hee-Jeong Im
Journal:  J Bone Miner Res       Date:  2016-04-08       Impact factor: 6.741

Review 4.  Role of vascular endothelial growth factor in adult hippocampal neurogenesis: implications for the pathophysiology and treatment of depression.

Authors:  Neil M Fournier; Ronald S Duman
Journal:  Behav Brain Res       Date:  2011-04-22       Impact factor: 3.332

5.  HDAC5 promotes optic nerve regeneration by activating the mTOR pathway.

Authors:  Wolfgang Pita-Thomas; Marcus Mahar; Avni Joshi; Di Gan; Valeria Cavalli
Journal:  Exp Neurol       Date:  2019-03-22       Impact factor: 5.330

6.  Down-regulation of nerve growth factor expression in the bladder by antisense oligonucleotides as new treatment for overactive bladder.

Authors:  Mahendra Kashyap; Naoki Kawamorita; Vikas Tyagi; Yoshio Sugino; Michael Chancellor; Naoki Yoshimura; Pradeep Tyagi
Journal:  J Urol       Date:  2013-02-27       Impact factor: 7.450

7.  Expression of nerve growth factor and hypoxia inducible factor-1α and its correlation with angiogenesis in non-small cell lung cancer.

Authors:  Qing-Li Lu; Jian Liu; Xiao-Li Zhu; Wen-Jia Xu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-06-18

8.  Changes in HIF-1α, VEGF, NGF and BDNF levels in cerebrospinal fluid and their relationship with cognitive impairment in patients with cerebral infarction.

Authors:  Xian-Jun Ke; Jun-Jian Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-06-17

9.  Nerve growth factor in diabetic retinopathy: beyond neurons.

Authors:  Barbara A Mysona; Ahmed Y Shanab; Sally L Elshaer; Azza B El-Remessy
Journal:  Expert Rev Ophthalmol       Date:  2014-04

10.  DNMT1, a Novel Regulator Mediating mTORC1/mTORC2 Pathway-Induced NGF Expression in Schwann Cells.

Authors:  Meijuan Cheng; Xin Lv; Cuihong Zhang; Wei Du; Yaping Liu; Lin Zhu; Jun Hao
Journal:  Neurochem Res       Date:  2018-09-18       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.